The global HER2-positive gastric cancer treatments market is expected to grow at a compound annual growth rate (CAGR) of 3.5%, with a current valuation of US$ 1261.8 million by 2023. Healthcare technology advancements are expected to drive the market to US$1779.8 million by 2033. The market for gastric cancer that is HER2-positive will likely experience rapid …
Tag Archives: HER2 Positive Gastric Cancer Market Forecast
Global HER2 Positive Gastric Cancer Market Set to Soar, Predicted to Reach US$1779.8 Million a Compound Annual Growth Rate CAGR of 3.5% by 2033
The global HER2-positive gastric cancer treatments market is poised for steady growth, reaching an estimated US$1.78 billion (USD$1,779.8 million) by 2033. This projection reflects a compound annual growth rate (CAGR) of 3.5% from a market value of US$1.26 billion (USD$1,261.8 million) in 2023. The market for HER2-positive gastric cancer will have tremendous growth potential as …